This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Medica Group Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Medica Group's earnings have been declining at an average annual rate of -4.4%, while the Healthcare industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 15.7% per year. Medica Group's return on equity is 11.8%, and it has net margins of 9.4%.

Información clave

-4.4%

Tasa de crecimiento de los beneficios

-7.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	15.7%
Tasa de crecimiento de los ingresos	15.7%
Rentabilidad financiera	11.8%
Margen neto	9.4%
Última actualización de beneficios	31 Dec 2022

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Medica Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

DB:2MI Ingresos, gastos y beneficios (GBP Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 22	77	7	26
30 Sep 22	74	7	25
30 Jun 22	71	7	23
31 Mar 22	67	6	22
31 Dec 21	62	5	20
30 Sep 21	54	4	18
30 Jun 21	46	2	16
31 Mar 21	42	2	14
31 Dec 20	37	1	12
30 Sep 20	39	3	12
30 Jun 20	42	5	12
31 Mar 20	44	6	11
31 Dec 19	47	8	11
30 Sep 19	44	8	10
30 Jun 19	42	8	8
31 Mar 19	41	8	8
31 Dec 18	39	7	7
30 Sep 18	38	7	8
30 Jun 18	37	7	8
31 Mar 18	35	6	7
31 Dec 17	34	4	6
30 Sep 17	32	3	6
30 Jun 17	31	2	5
31 Mar 17	30	3	5
31 Dec 16	29	3	5
30 Sep 16	27	3	5
31 Dec 15	22	2	4
31 Dec 14	18	0	4
31 Dec 13	14	-1	5

Ingresos de calidad: 2MI has high quality earnings.

Margen de beneficios creciente: 2MI's current net profit margins (9.4%) are higher than last year (8.8%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 2MI's earnings have declined by 4.4% per year over the past 5 years.

Acelerando crecimiento: 2MI's earnings growth over the past year (31.7%) exceeds its 5-year average (-4.4% per year).

Beneficios vs. Industria: 2MI earnings growth over the past year (31.7%) exceeded the Healthcare industry -23.9%.

This company listing is no longer active

Medica Group Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2022 earnings released: EPS: UK£0.059 (vs UK£0.046 in FY 2021)

Full year 2022 earnings released: EPS: UK£0.059 (vs UK£0.046 in FY 2021)

First half 2022 earnings released: EPS: UK£0.029 (vs UK£0.015 in 1H 2021)

Medica Group Plc to Report First Half, 2022 Results on Sep 26, 2022

Full year 2021 earnings released: EPS: UK£0.046 (vs UK£0.012 in FY 2020)

First half 2021 earnings released: EPS UK£0.015 (vs UK£0.007 in 1H 2020)

Recent updates

Medica Group Plc(LSE:MGP) dropped from FTSE All-Share Index (GBP)

Medica Shares to Delist from the Premium Listing Segment of the Official List on the London Stock Exchange's Main Market for Listed Securities on 7 July 2023

New minor risk - Shareholder dilution

Upcoming dividend of UK£0.019 per share at 1.3% yield

Medica Group Plc, Annual General Meeting, Jun 30, 2023

Full year 2022 earnings released: EPS: UK£0.059 (vs UK£0.046 in FY 2021)

Investor sentiment improves as stock rises 36%

Full year 2022 earnings released: EPS: UK£0.059 (vs UK£0.046 in FY 2021)

Investor sentiment improved over the past week

First half 2022 earnings released: EPS: UK£0.029 (vs UK£0.015 in 1H 2021)

Medica Group plc Announces Dividend for the Six Months Ended June 30, 2022, Payable on November 04, 2022

Medica Group Plc to Report First Half, 2022 Results on Sep 26, 2022

Medica Group Plc Provides Revenue Guidance for the Half Year Ended June 30, 2022

Medica Group plc Approves Election of Barbara Moorhouse as Director

Upcoming dividend of UK£0.018 per share

High number of new directors

High number of new directors

Full year 2021 earnings released: EPS: UK£0.046 (vs UK£0.012 in FY 2020)

Medica Group Plc Proposes Final Dividend for the Year 2021, Payable on July 22, 2022

Medica Group plc Provides Revenue Guidance for 2021

First half 2021 earnings released: EPS UK£0.015 (vs UK£0.007 in 1H 2020)

Senior Independent Non-Executive Director Stephen Whittern has left the company

Upcoming dividend of UK£0.017 per share

Group Medical Director, Responsible Officer & Executive Director has left the company

Full year 2020 earnings released: EPS UK£0.012 (vs UK£0.071 in FY 2019)

Medica Group Plc Proposes Final Dividend for the Year 2020, Payable on July 23, 2021

Junaid Bajwa Joins the Board of Medica Group plc as Non-Executive Director and Chair of the Clinical and Risk Committee on the April 1, 2021

Investor sentiment improved over the past week

Medica Group plc and Integral Diagnostics Limited Announce an Equal Joint Venture Partnership, Medx

New 90-day low: €1.27

Medica Group Plc to Report Fiscal Year 2020 Final Results on Apr 01, 2021

Medica Group plc Announces Board Changes

New 90-day high: €1.46

Medical Director recently sold €1.4m worth of stock

Market bids up stock over the past week

Medica Group Plc (LSE:MGP) entered into an agreement to acquire Global Diagnostics (Ireland) Limited from Centric Health for €20 million.

New 90-day low: €1.23

New 90-day low: €1.31

First half earnings released

New 90-day high - €1.55

Medica Group Plc to Report First Half, 2020 Results on Sep 14, 2020

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado